# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-018458
Filing Date
2023-04-14
Accepted
2023-04-14 16:15:43
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20006407x4_defa14a.htm | DEFA14A | 28021
2 |  | ny20006407x4_nc1.jpg | GRAPHIC | 991305
3 |  | ny20006407x4_nc2.jpg | GRAPHIC | 699826
4 |  | ny20006407x4_sig.jpg | GRAPHIC | 1693
| Complete submission text file | 0001140361-23-018458.txt |  | 2104502

Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35024 | Film No.: 23821339
SIC: 2833 Medicinal Chemicals & Botanical Products